Infliximab-induced eczematoid eruption.
Rodríguez-Martín
M
M
Sáez
M
M
Carnerero
A
A
García-Bustínduy
M
M
Guimerá
A
A
Rodríguez García
F
F
Cabrera de Paz
R
R
Sidro
M
M
Sánchez
R
R
Martín Herrera
A
A
Noda
A
A
D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D003875:Drug Eruptions; D004485:Eczema / Q000139:chemically induced*; D004890:Erythema / Q000473:pathology; D005260:Female; D006801:Humans; D000069285:Infliximab; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab